SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-016297
Filing Date
2016-04-15
Accepted
2016-04-15 17:06:26
Documents
5
Period of Report
2016-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-8k_20160411.htm 8-K 44064
2 EX-10.1 crbp-ex101_14.htm EX-10.1 21123
3 EX-10.2 crbp-ex102_15.htm EX-10.2 25400
4 EX-10.3 crbp-ex103_16.htm EX-10.3 36677
5 EX-10.4 crbp-ex104_17.htm EX-10.4 144853
  Complete submission text file 0001564590-16-016297.txt   273419
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 161575099
SIC: 2834 Pharmaceutical Preparations